ArticleScientific reports2021

Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.

Kenro Tanoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.